Key Takeaways
- Record quarter, structurally stronger: Q1 PAT already covered over 65% of FY26’s full-year profit, driven by better realizations across ammonia, mining chemicals and industrial chemicals, plus the first benefits of the integrated gas-to-ammonia value chain.
- New capacities are imminent, ramp-up expected fast: Gopalpur TAN and Dahej nitric acid projects are at ~96% and ~93% completion and should start commissioning toward the end of Q2 FY27; management expects faster-than-typical ramp-up because the chemistry and plant type are familiar.
- Equinor LNG is live and delivering: The first cargo arrived in May 2026, gas availability issues are resolved, and the ammonia plant is debottlenecked and running at ~10% higher capacity; the phase-in of cost-effective Equinor gas will complete by Q4 FY27.
- Debt is near its peak: Net debt stands at ₹4,719 crores (1.4x debt/EBITDA) despite over ₹500 crores of capex in the quarter; management expects deleveraging to begin this year as new capacities start contributing.
- What to watch next quarter: Commissioning milestones at Gopalpur and Dahej, the pace of TAN volume normalization after the PESO disruption, and any movement on the DMSL listing decision.
Integrated Value Chain & Structural Change
- Gas-to-ammonia integration is the undercurrent strength: The Equinor LNG contract, ammonia plant debottlenecking, and backward integration are delivering resilience, risk mitigation and cost optimization that management believes permanently reduces the severe volatility the business has seen in the past.
- Ammonia plant now running above nameplate: After resolving an April gas availability issue with the first Equinor cargo in May, the debottlenecked plant is operating at ~10% higher capacity, and selling surplus merchant ammonia is a normal, well-instituted part of the business model.
- Equinor ramp-up has a clear timeline: The proportion of Equinor gas will keep increasing as legacy government gas supply contracts expire; the phase-in/phase-out will be completed by Q4 FY27, at which point Equinor gas will be more than enough to meet the company’s requirement, eliminating dependence on any other gas source.
- Savings are sizable but not pinned down: Management declined to share the exact annual savings number but acknowledged that if market conditions remain broadly similar, the ~₹300 crores savings figure cited by an analyst is right, though it can move with crude, Henry Hub or international prices.
- Ammonia prices likely to settle at a new elevated level: Current prices around $600 may soften if the Middle East war stabilizes, but management and international prognosis both suggest prices will not fall to previous levels soon; no major new supply from China is expected immediately.
Subhash Anand: "With these things in place, what we are confident as a management, the kind of a volatility the business has seen in past, will not have a similar volatility. Yes, some volatility will continue. That's business... But the severe volatility what we have seen in past, that may not be a reality for us in in the coming future, and that's what we believe." [9–10]
Mining Chemicals & TAN
- Volume disruption was temporary and logistical: TAN volumes fell to 130 KT because new PESO guidelines disturbed the outward logistics supply chain for a few days, causing a production loss; it was not a raw material, production or demand issue, and the disruption is now behind the company.
- Realizations drove revenue up 37% YoY despite the volume dip: Stronger pricing, elevated ammonia prices from the Middle East conflict, and backward integration benefits all contributed; B2C revenue grew 42% to ₹151 crores.
- Near-term margin outlook is favorable: Elevated TAN prices may sustain for some time because the Middle East conflict has not resumed, and the company is factually more favorably placed due to backward integration and a global supply crunch.
- Medium-term supply-demand looks balanced: Even with new competitor capacities entering, 6–7% annual market growth means the market is not expected to be very long; management sees no drastic tilt in supply-demand dynamics and expects margins to remain consistent over the medium to long term, excluding unforeseen events.
- Explosives acquisition adds a downstream leg: The company completed the acquisition of an explosives company in May 2026; the facility is being upgraded to safety and quality standards, and once the full range of explosives is available, products will be rolled out commercially under a Total Cost of Ownership (TCO) outcome-based business model.
Tarun Sinha: "Whereas in the DMSLs TCO model certainly it supplies explosives along with blasting tools, technology, people competency and things like that but, there is an outcome which we will guarantee. So it is an outcome based model and that is where the difference comes in rather than just being an input driven model..."
Industrial Chemicals
- Nitric acid is a stable, predictable franchise: Merchant sales volume was flat YoY at ~80 KT; the business runs on long-term contracts linked to feedstock, and the new Dahej capacity will improve both top-line and EBITDA once operational.
- Weak nitric acid production dipped QoQ partly on lower captive TAN demand: Total weak nitric acid production fell from 2.35 lakh tons to ~2 lakh tons, partly because captive nitric acid cannot always be easily placed outside when internal demand drops suddenly.
- IPA is recovering: The business has started seeing recovery from Q1 onward after past challenges with RGP availability, which is now improving; stronger pharma-grade demand and improved realizations supported profitability even while volumes were constrained by propylene availability.
- Long-term average is the IPA benchmark: Management expects to maintain the long-term average in the IPA business, with some quarter-on-quarter volatility; volumes are expected to progressively recover as propylene availability improves.
Crop Nutrition
- Challenging quarter, still grew 9% YoY: Delayed monsoon, elevated input costs and inadequate subsidy alignment created a difficult environment, but manufactured NPK sales grew 4% and the premiumization strategy remains on track.
- Q2 should improve with the monsoon: Widespread rains and the El Niño worry being behind support a good pick-up in the fertilizer and crop nutrition business, though sourcing and prices of phos acid, sulphur and other raw materials will remain under strain from the Middle East war scenario.
- Near-term subsidy risk: Management flagged that faster decisions on subsidy corrections by the government will be needed to offset raw material cost pressure.
New Capacities & the Earnings Inflection
- Both projects are on the cusp of commissioning: Gopalpur TAN is at ~96% completion and Dahej nitric acid at ~93%; both remain within the approved capex envelope and are expected to commence operations towards the end of Q2 FY27.
- Ramp-up is expected to be faster than typical: Because neither project involves new chemistry or a new plant type for the company, management expects good utilization from Q4 FY27; if all goes well, utilization could ramp to around 80% in Q4 FY27.
- New capacities will change the base level of earnings: Both projects will start contributing to the bottom line from Q3 onward, and definitely in Q4; by the end of FY27, the base level of earnings will be at an elevated “new normal.”
- These are working-capital-efficient businesses: Both Gopalpur and Dahej are B2B and not heavy on working capital, so cash flow from these businesses will be better, supporting the deleveraging story.
Subhash Anand: "By the time we end this year, our base level will change from where we started, I call it. So, the new normal level will start reflecting in our results, and that’s what we foresee. The new level will be an elevated level by the time we end this year."
Balance Sheet & Deleveraging
- Debt is near its peak: Net debt stands at ~₹4,700–₹4,800 crores, and while there may be some more debt in the last leg of project completion, management believes the debt level has broadly reached its peak.
- Deleveraging starts this year: As new capex contributes to EBITDA and cash flow, deleveraging of the balance sheet is expected to begin from this year onward; debt/EBITDA already improved to 1.4x despite over ₹500 crores of capex in the quarter.
- DMSL listing is committed in principle: The form (demerger vs IPO) is yet to be decided and will be communicated in due course; all options will be evaluated to find what is beneficial for all stakeholders.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Gopalpur TAN and Dahej nitric acid commissioning | Both projects to commence operations | Towards end of Q2 FY27 |
| New capacity ramp-up | Ramp to ~80% utilization if all goes well | Q4 FY27 |
| Equinor gas phase-in/phase-out completion | Equinor becomes sole gas source, eliminating dependence on other sources | Q4 FY27 |
| Deleveraging start | Balance sheet deleveraging to begin as new capex contributes | FY27 |
| Earnings base-level reset | New, elevated “new normal” earnings level reflecting new capacities | By end of FY27 |
| DMSL listing | Form (demerger vs IPO) to be decided and communicated | In due course |
| TAN volume normalization | Y-o-Y volumes expected to be normal | Q2 FY27 onward |
| Elevated ammonia prices | Disturbance expected to continue | At least 2–3 more quarters |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Consolidated revenue | ₹3,256 cr, up 22% YoY and 8% QoQ |
| Operating EBITDA | ₹845 cr (record), up 65% YoY and 139% QoQ |
| EBITDA margin | 26%, vs 19% in Q1 FY26 and ~12% in Q4 FY26 |
| Net profit | ₹490 cr, up 101% YoY and 252% QoQ |
| Net debt | ₹4,719 cr, debt/EBITDA improved to 1.4x from 2.86x |
| Mining chemical revenue | ~₹911 cr, up 37% YoY |
| Mining chemical volume | 130 KT, lower due to temporary PESO portal disruption |
| Mining chemical B2C revenue | ₹151 cr, up 42% YoY, 17% of segment revenue |
| Industrial chemical revenue | ~₹490 cr |
| Crop nutrition revenue | ~₹1,367 cr, up 9% YoY |
| Manufactured NPK sales growth | 4% YoY |
| Specialty and Croptek contribution | 43% of crop nutrition segment revenue |
| Ammonia plant capacity utilization | 94% average, post-debottlenecking ~10% capacity improvement achieved |
| Gopalpur TAN project completion | ~96%, commissioning expected Q2 FY27 |
| Dahej nitric acid project completion | ~93%, commissioning expected Q2 FY27 |
| Q1 FY27 capex incurred | Over ₹500 cr, total spending till Q1 ~₹3,850 cr |